Oral Supplementation to Enhance Recovery Pilot Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
Malignant Neoplasms of Urinary Tract
Interventions
DRUG

Arginine recovery supplement

Participants take 1 ounce (30mls) of Arginine recovery supplement four times daily 5 days preoperatively and 14 days postoperatively.

DIETARY_SUPPLEMENT

Omega-3 Fatty Acids

Participants given omega-3 fatty acids, 1 gram four times a day, 4 grams total per day. This will be started 7 days preoperatively and continued 14 days postoperatively.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03204266 - Oral Supplementation to Enhance Recovery Pilot Study | Biotech Hunter | Biotech Hunter